Table 3 A comparison of the CGC enrichment analyses between our method and the SSN method
From: Identifying network biomarkers of cancer by sample-specific differential network
BRCA | top-10 | top-20 | top-30 | top-50 | top-100 |
|---|---|---|---|---|---|
Our method | 99.82% | 100.00% | 100.00% | 100.00% | 100.00% |
SSN method | 23.96% | 25.41% | 34.03% | 55.63% | 80.03% |
LUAD | top-10 | top-20 | top-30 | top-50 | top-100 |
Our method | 99.62% | 100.00% | 100.00% | 100.00% | 100.00% |
SSN method | 16.89% | 22.14% | 24.39% | 50.09% | 76.55% |
LUSC | top-10 | top-20 | top-30 | top-50 | top-100 |
Our method | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
SSN method | 7.37% | 10.76% | 12.95% | 32.07% | 69.52% |
LIHC | top-10 | top-20 | top-30 | top-50 | top-100 |
Our method | 98.92% | 99.73% | 100.00% | 100.00% | 100.00% |
SSN method | 10.78% | 10.51% | 15.36% | 30.19% | 60.91% |